Alpha Healthcare Acquisition Corp. III
Status: Closed Deal
U=S+W/4
W=S@11.50
| IPO Proceeds, $M | $154.44M |
|---|---|
| IPO Date | Jul 27, 2021 |
| CEO | Rajiv Shukla |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | Carmell Therapeutics |
| Deal Announced | Jan 4, 2023 |
| Deal Size, $M | $328.39M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 11, 2023 |
| Amendment Vote | TBD |
| Closing Date | Jul 14, 2023 |
Formerly ALPA
XAGE
CTCXW
| Price | $0.39 $0.01 |
|---|---|
| Last closing price | $2.32 |
| H/L, today | $0.39 / $0.55 |
| Volume, today | 646 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.